12:00 AM
 | 
Aug 06, 2012
 |  BC Week In Review  |  Company News  |  Deals

NantWorks, Prometic deal

ProMetic and NantWork's NantPharma LLC company formed newco NantPro BioSciences LLC to develop and commercialize in the U.S. a plasma-derived product for an undisclosed indication. ProMetic granted the newco exclusive rights to its plasma protein purification system (PPPS) and prion reduction technologies to develop and...

Read the full 202 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >